動物疼痛管理的全球市場 (2022-2028年):各藥物類型、動物類型、終端用戶、給藥途徑、流通管道的規模、佔有率、成長分析、預測

Global Veterinary Pain Management Market Size, Share, Growth Analysis, By Drug Type, By Animal Type, By End Users, By Route of Administration, By Distribution Channel - Industry Forecast 2022-2028

出版日期: 2022年11月13日 | 出版商:

SkyQuest | 英文 272 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球動物疼痛管理的市場規模，從2021年的13億5,000萬美元，在預測期間中預計以7％的年複合成長率發展，2028年成長到21億5,000萬美元的規模。

寵物的疾病盛行率的上升促進該市場的成長。根據Animal Cancer Foundation，2018年在美國有6,000萬頭以上的狗和3,000萬頭以上的貓診斷出末期癌症。獸醫數增加，已開發國家的獸醫工資水準的上升，低成本治療的需求高漲，動物的健康和福利相關意識的高漲等要素也促進在預測期間內的市場成長。

本報告提供全球動物疼痛管理的市場調查，市場概要，市場的各種影響因素的分析，技術、革新趨勢，市場規模的變化、預測，各種區分、各地區的明細，競爭情形，主要企業簡介等彙整資訊。

市場概要
市場規模
市場動態
促進因素
機會
阻礙因素
課題
主要市場洞察
技術分析
價格分析
供應鏈分析
價值鏈分析
市場生態系統
IP分析
貿易分析
Start-Ups分析
原料分析
革新矩陣
開發中產品分析
宏觀經濟指標
主要投資分析
主要的成功因素
競爭的程度
市場動態與展望
市場動態
促進因素
機會
阻礙因素
課題
法規情形
波特分析
未來的阻礙相關Skyquest的特別洞察
全球動物疼痛管理市場:各藥物類型
市場概要
類鴉片物質
嗎啡
Hydromorphone
可待因
α2-腎上腺素促效劑
Xylazine
Medetomidine
局部麻醉劑
Bupivacaine
Lidocaine
Chloropropane
非類固醇系抗發炎藥(NSID)
Etodolac
吩坦尼
Meloxicam
鎮靜劑
皮質類固醇
其他
全球動物疼痛管理市場:各動物類型
市場概要
家畜
寵物
全球動物疼痛管理市場:各終端用戶
市場概要
動物醫院藥局
零售動物藥局
線上藥局
全球動物疼痛管理市場:各給藥途徑
市場概要
口服
非口服
全球動物疼痛管理市場:各流通管道
市場概要
動物醫院
藥局
全球動物疼痛管理市場:各地區
市場概要
北美
歐洲
亞太地區
南美
中東、非洲
競爭情形
主要5家公司的比較
主要企業的市場定位
主要企業的採用策略
主要成功策略
市場上最近的活動
主要企業的市場佔有率
主要企業簡介
Zoetis
Elanco
Bayer AG
Norbrook
Ceva
Dechra Pharmaceuticals
Assisi Animal Health
Merck Sharp &Dohme Corp
Boehringer Ingelheim International GmbH
Virbac
IDEXX Laboratories
Vetoquinol
Evonik Industries AG
DuPont
DSM
Adisseo
BASF SE
ADM
Nutreco
Novusint
Cargill Incorporated
Charoen Pokphand Group
Sumitomo Chemical
Kemin Industries, Inc.
Medtronic

簡介目錄

Product Code: SQMIG35I2099

Veterinary Pain Management Market size was valued at USD 1.35 billion in 2021 and is expected to reach USD 2.15 billion by 2028, at a CAGR of 7% during the forecast period (2022-2028).

Veterinary pain management includes diagnostic testing, prevention, and treatment of pain in animals caused by a variety of variables including as vital organ disorders, physical damage, central nervous system and spinal problems, and surgical methods. Practitioners must be able to recognise and relieve pain in a wide range of pet diseases in order to control pain in the veterinary industry. Pain in animals can be caused by a variety of circumstances, including arthritis, cancer, surgical intervention, and so on. Pain can also be connected with aggressive behavior, diminished or complete loss of activity, and other symptoms in animals. Pet and agricultural animal performance can be affected by animal discomfort.

The rising prevalence of pet ailments is driving growth in the Veterinary Pain Management Market. According to the Animal Cancer Foundation, more than 60 million dogs and 30 million cats in the United States were diagnosed with terminal cancer in 2018. The increasing number of veterinary practitioners, as well as rising veterinary practitioner salary levels in developed countries, are two significant drivers driving total expansion. Furthermore, rising demand for low-cost treatment procedures, as well as greater awareness about animal health and welfare, are likely to fuel the growth of the Veterinary Pain Management Market over the forecast period.

Top-down and bottom-up approaches were used to estimate and validate the size of global Veterinary Pain Management Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Segments covered in this report:

Global veterinary pain management market is segmented based on drug type, animal type, end users, route of administration, distribution channel, region. Based on drug type Veterinary Pain Management Market is segmented into Opioids, Morphine, Hydromorphone, Codeine, α2-adrenergic Agonists, Xylazine, Medetomidine, Local Anaesthetics, Bupivacaine, Lidocaine, Chloropropane, Nonsteroidal Anti-inflammatory Drugs (NSIDs), Etodolac, Fentanyl, Meloxicam, Sedatives, Corticosteroids, Others. Based on animal type Veterinary Pain Management Market is segmented as Livestock animal, Companion animal. Based on end user, the Veterinary Pain Management Market is segmented as Veterinary Hospital pharmacies, Retail Veterinary Pharmacies, Online Pharmacies. Based on route of administration Veterinary Pain Management Market is segmented as Oral Preparations, Parenteral Preparations. Based on distribution channel Veterinary Pain Management Market is segmented as veterinary hospitals, pharmacies. Based on region market is segmented into North America, Asia Pacific, Europe, Latin America and Middle East Africa.

Drivers

Increasing animal welfare funding to drive market growth. The increase in companion animal ownership and big livestock population, the increase in pet insurance with an increase in animal welfare spending, and the increased prevalence of animal diseases are all projected to have an impact on the expansion of the worldwide veterinary pain treatment sector. Furthermore, the rise of the sector is being pushed by an increase in the necessity to preserve animal health and safety in industrialised countries, as well as an increase in global acceptability of pet insurance. Furthermore, the increased prevalence of animal diseases that cause pain and inflammation is moving the sector ahead. Over the projection period, the expanding number of pet owners worldwide is expected to boost industry growth.

Restraint

High R&D expenditures, inadequate infrastructure, uneven distribution of medical services, and a lack of awareness in developing nations are projected to hinder industry expansion. Furthermore, a lack of favourable reimbursement scenarios and technology penetration in developing economies, a decline in advanced-country healthcare expenditures, high costs associated with pet care, and a lack of suitable infrastructure in low- and middle-income countries are expected to pose challenges to the market during the forecast period.

Market Trends

Exploration of undiscovered markets is being expanded in order to offer growth prospects for important companies. In comparison, the growing use of non-traditional and non-pharmaceutical treatment approaches, as well as unexplored new markets, are predicted to provide the industry with future growth potential.